3 recruiting, 2 completed, 1 not yet recruiting, 1 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Recruiting 3, Completed 2, Not yet recruiting 1, Unknown 1 |
Follow pertuzumab: new trials by email Literature Review of pertuzumab trials Research Report on pertuzumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer olaparib combined with trastuzumab and pertuzumab - Elderly Females, HER2 + Breast Cancer | Phase 4 | Recruiting | Wen-Ming Cao | 45 | 2026-05-25 | 2026-07-10 |
| Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer lobaplatin, carboplatin, Docetaxel or albumin paclitaxel - Breast Cancer | Phase 4 | Not yet recruiting | Shandong Cancer Hospital and Institute | 468 | 2025-08-01 | 2025-07-30 |
| A Study for the Adjuvant Treatment of Breast Cancer Docetaxel, Carboplatin, Trastuzumab - Breast Cancer | Phase 4 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2413 | 2022-07-10 | 2022-07-01 |
| A Study for the Neoadjuvant Treatment of Breast Cancer Docetaxel, Carboplatin, Trastuzumab - Breast Cancer | Phase 4 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 1576 | 2022-07-10 | 2022-07-01 |
| Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON) Ontruzant, Chemotherapy, Pertuzumab - Breast Cancer, Breast Neoplasms | Phase 4 | Unknown | Institut fuer Frauengesundheit | 108 | 2021-07-11 | 2023-04-18 |
| Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer Docetaxel, Pertuzumab, Trastuzumab - Breast Cancer | Phase 4 | Completed | Hoffmann-La Roche | 52 | 2015-08-17 | 2019-10-29 |
| MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I TAC chemotherapy, TC chemotherapy, Dose Dense AC or FEC100 followed by paclitaxel or docetaxel chemotherapy - Breast Cancer | Phase 4 | Completed | Agendia | 226 | 2011-10-01 | 2018-06-28 |
Breast Neoplasms (7)
Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Agendia (1) · Hoffmann-La Roche (1) · Institut fuer Frauengesundheit (1) · Shandong Cancer Hospital and Institute (1) · Wen-Ming Cao (1)
China (4) · Germany (1) · India (1) · United States (1)
Andreas Schneeweiss, MD, Prof. (1) · Anil Kukreja, MD (1) · Charles E Cox, MD (1)